T 1203/19 (Oncolytic adenoviruses/INSTITUT CATALA D'ONCOLOGIA) of 26.04.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T120319.20220426
- Date of decision
- 26 April 2022
- Case number
- T 1203/19
- Petition for review of
- -
- Application number
- 10772050.0
- IPC class
- C12N 9/26C12N 15/861A61K 48/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- ONCOLYTIC ADENOVIRUSES FOR TREATING CANCER
- Applicant name
- Fundació Privada Institut D'investigació Biomèdica
Institut Català D'Oncologia - Opponent name
- Hoffmann Eitle Patent- und Rechtsanwälte PartmbB
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 104(1)European Patent Convention Art 112a(2)(c)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention R 106
- Keywords
- Second auxiliary request - novelty - (yes)
Inventive step - (yes)
Apportionment of costs - (no)
Objection under Rule 106 - under condition (dismissed) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1 to 18 of the second auxiliary request filed with the statement setting out the grounds of appeal, and a description to be adapted.
3. The request for apportionment of costs is refused.